SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-216302
Filing Date
2005-11-04
Accepted
2005-11-04 08:00:41
Documents
4
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 411128
2 CERTIFICATION OF CEO dex311.htm EX-31.1 10004
3 CERTIFICATION OF CFO dex312.htm EX-31.2 10373
4 CERTIFICATION OF CEO & CFO dex32.htm EX-32 6978
  Complete submission text file 0001193125-05-216302.txt   439802
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 051178572
SIC: 2836 Biological Products, (No Diagnostic Substances)